Concepedia

Michael Sturdivant

MS

2

Publications

313

Citations

2

H-Index

2020

Active since

Affiliations

Duke University(Current)

University of North Carolina at Chapel Hill

Michael Sturdivant is an author at Duke University specializing in cancer research, tumor immunity, and tumor immunology.

ORCID

Top concepts

Publications per year

2020–2021

2

Publications

2

A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti–PD-1 immunotherapy

Balamayoora Theivanthiran, Kathy S. Evans, Nicholas C. DeVito et al. · Journal of Clinical Investigation · 2020 · 235 citations · Full text

, , +19

Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy

Nicholas C. DeVito, Michael Sturdivant, Balamayooran Thievanthiran et al. · Cell Reports · 2021 · 78 citations · Full text

Rows per page

1–2 of 2